Discontinued — last reported Q4 '23
ResMed Payments for (Proceeds from) Derivative Instrument, Investing Activities decreased by 294.1% to -$24.07M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 504.9%, from $5.95M to -$24.07M.
Fluctuations reflect the effectiveness of hedging strategies and market volatility impacting the company's risk management positions.
This captures the net cash impact of derivative financial instruments used for hedging or speculative purposes. It refle...
Commonly reported in the investing or operating section depending on the nature of the hedge.
other_payments_for_proceeds_from_derivative_instrument_i_724843| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.48M | $1.94M | -$110.00K | $11.87M | $3.04M | -$10.22M | -$11.78M | $1.50M | $5.46M | $4.58M | -$18.98M | $11.80M | $5.95M | -$40.41M | $4.10M | $12.41M | -$24.07M |
| QoQ Change | — | -44.3% | -105.7% | >999% | -74.4% | -436.1% | -15.2% | +112.7% | +263.4% | -16.1% | -514.6% | +162.2% | -49.6% | -779.7% | +110.2% | +202.3% | -294.1% |
| YoY Change | — | — | — | — | -12.6% | -627.5% | <-999% | -50.7% | +153.4% | +138.9% | <-999% | +116.4% | +29.9% | — | +121.6% | +5.1% | -504.9% |